Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes
|
Dec 2020
|
Hematology/oncology and stem cell therapy
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment
|
Sep 2016
|
Immunobiology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients
|
Jan 2016
|
Immunobiology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders
|
Nov 2012
|
Immunobiology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.
|
Nov 2013
|
Immunol Res
|
aplastic anemia
|
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia
|
Dec 2023
|
Immunotherapy
|
aplastic anemia
|
Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy.
|
Jun 2013
|
Immunotherapy
|
myelodysplastic syndromes (MDS)
|
Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India.
|
Feb 2017
|
Indian J Hematol Blood Transfus
|
aplastic anemia
|
Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed
|
Dec 2016
|
Indian J Hematol Blood Transfus
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Immunosuppressive Therapy in Aplastic Anemia.
|
Jan 2012
|
Indian J Pediatr.
|
aplastic anemia
|